HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via ISI Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Fogarty, A. Articles by Britton, J. Search for Related Content PubMed PubMed Citation Articles by Fogarty, A. Articles by Britton, J.

Amino acids and asthma: a case-control study

¹ Division of Respiratory Medicine, ² Dept of Clinical Chemistry, and ³ Division of Epidemiology and Public Health, University of Nottingham, Clinical Sciences Building, City Hospital, Nottingham, UK

CORRESPONDENCE: A. Fogarty, Division of Respiratory Medicine, Clinical Science Building, City Hospital, Hucknall Rd, Nottingham NG5 4JB, UK. Fax: 44 1158404771. E-mail: andrew.fogarty@nottingham.ac.uk

Keywords: amino acids, asthma, cystine

Received: August 5, 2003
Accepted November 17, 2003

This study was funded by the British Lung Foundation and the University of Nottingham.

Amino acids contribute to various anti-oxidant and immunological activities relevant to asthma pathogenesis, raising the possibility that differences in amino acids may be involved in asthma aetiology. The authors hypothesised that cystine reduces the risk of asthma via glutathione metabolism. Methionine, glutamine, glutamic acid and glycine may have potential protective effects, whilst arginine, phenylalanine and tryptophan may have adverse effects in asthma.

Fasting plasma levels of amino acids were compared in a case-control study. A total of 89 adults, aged 18–65 yrs, with asthma controlled by inhaled corticosteroids, were recruited from a volunteer database and local primary care registers, and compared with 89 controls individually matched for age, sex and primary care centre.

Contrary to the primary hypothesis, cases had higher fasting plasma cystine levels than controls, and there was no difference between cases and controls in any of the other amino acids tested, with the exception of plasma glycine, which was associated with a strongly reduced risk of asthma (odds ratio for the highest tertile compared to lowest 0.30 (95% confidence interval (0.11–0.82)).

This study negates the hypothesis that higher fasting plasma cystine levels have a protective effect on the risk of asthma, although the inverse correlation with plasma glycine deserves further investigation.